Belkin Laser Revenue and Competitors
Estimated Revenue & Valuation
- Belkin Laser's estimated annual revenue is currently $6.8M per year.
- Belkin Laser's estimated revenue per employee is $251,000
Employee Data
- Belkin Laser has 27 Employees.
Belkin Laser's People
Name | Title | Email/Phone |
---|
Belkin Laser Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Belkin Laser?
BELKIN Laser is developing an automated one-second laser device, aimed at revolutionizing accessibility to glaucoma care worldwide. • Treatment is aimed at revolutionizing accessibility to glaucoma care by becoming the first-line choice for glaucoma therapy for every patient, all over the world. • BELKIN Laser is addressing the growing disparity between the enormous number of glaucoma patients (67M) and the limited number of ophthalmologists (212.000), by enabling the doctor to treat many more patients. • BELKIN's innovative technology is applicable for the prevalent Open Angle Glaucoma (OAG, 70% of total glaucoma patients) and it will pioneer laser treatment for Angle Closure Glaucoma (ACG, 30%), which is most common among Asian populations. • The innovative solution provides treatment that is patient friendly - non-invasive, non-contact, instantaneous & painless.
keywords:N/AN/A
Total Funding
27
Number of Employees
$6.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 33 | 6% | N/A |
#2 | $20.3M | 131 | 13% | N/A |
#3 | $3.5M | 137 | -19% | N/A |
#4 | $201.4M | 523 | 5% | N/A |